BioAtla, Inc. (BCAB) vs Clearmind Medicine Inc. (CMND)

BioAtla, Inc. and Clearmind Medicine Inc. are both Biotechnology companies. BioAtla, Inc. and Clearmind Medicine Inc. are of similar size ($2.9M and $2.8M). Clearmind Medicine Inc. has the higher net margin (0.00% vs −177.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Clearmind Medicine Inc. leads on 7 and BioAtla, Inc. on 5.

Valuation

Metric BCAB CMND Biotechnology median
P/E n/m n/m 7.88
P/S 0.14 n/m 11.47
P/B n/m 0.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 1.46 0.74
EV/Sales 0.21 n/m 10.73
Earnings yield (1,719.59%) (11,553.20%) (28.84%)
Free cash flow yield (959.44%) (558.57%) (23.03%)

Profitability

Metric BCAB CMND Biotechnology median
Gross margin 95.44% 0.00% 65.16%
Operating margin (180.99%) 0.00% 0.00%
Net margin (177.21%) 0.00% 0.00%
Free cash flow margin (132.29%) 0.00% 0.00%
Return on equity 118.74% (106.98%) (57.72%)
Return on assets (171.72%) (71.81%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCAB CMND Biotechnology median
Revenue growth (TTM) 574.65% — 5.64%
EPS growth (last fiscal year) 29.86% 55.10% —
Revenue growth, 5-year CAGR (28.40%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCAB CMND Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 0.20 4.31 4.73
Net debt to EBITDA 0.12 0.68 0.96

Dividend

Metric BCAB CMND Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric BCAB CMND Biotechnology median
Market cap 2.89m 2.83m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack